Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.
Recent research findings indicate that depressive disorders may be divided into two groups, A and B, using specific biochemical and pharmacological criteria. It is suggested that in the A group there is a disorder of norepinephrine systems are not altered. Further, there is the possibility that B types patients have disorder of serotonin, but not norepinephrine or dopamine systems. This biochemical heterogeneity of human depression has implications for both investigators and clinicians, and may account for disparate findings in biological studies of patients with affective disorders.
D000639:Amitriptyline / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism*; D003863:Depression / Q000145:classification / Q000188:drug therapy / Q000378:metabolism*; D003891:Desipramine / Q000627:therapeutic use; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000627:therapeutic use; D007099:Imipramine / Q000627:therapeutic use; D008676:Metanephrine / Q000378:metabolism; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D009647:Normetanephrine / Q000378:metabolism; D009661:Nortriptyline / Q000627:therapeutic use; D014642:Vanilmandelic Acid / Q000378:metabolism
D001679:Biogenic Amines; D009647:Normetanephrine; D000639:Amitriptyline; D008676:Metanephrine; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D014642:Vanilmandelic Acid; D009661:Nortriptyline; D007099:Imipramine; D003891:Desipramine; D003913:Dextroamphetamine